Typ-1-Diabetes
Sodium Glucose Cotransporter Inhibitor - an overview | ScienceDirect Topics
Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, in overweight/obese patients with type 1 diabetes: addressing unmet needs as adjunct therapy to insulin - Media Centre | EASD
Frontiers | New insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure
SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
SGLT inhibitors: a novel target for diabetes | Pharmaceutical Patent Analyst
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus | SpringerLink
IJMS | Free Full-Text | Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases
SGLT inhibitors for type 1 diabetes: a finely balanced matter?
Structural mechanism of SGLT1 inhibitors | Nature Communications
Diabetes & Metabolism Journal
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control | Nature Reviews Cardiology
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus. - Abstract - Europe PMC
Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors - Yakovleva -
Development of SGLT1 and SGLT2 inhibitors | SpringerLink
Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF | Cardiovascular Diabetology | Full Text
The Na+‐D‐glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer | Semantic Scholar
Sodium–glucose cotransporters: Functional properties and pharmaceutical potential - Sano - 2020 - Journal of Diabetes Investigation - Wiley Online Library
Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care | Diabetes Technology & Therapeutics
SGLT Inhibitors
Role and regulation of intestinal SGLT1 for glucose uptake and... | Download Scientific Diagram
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives | Cardiovascular Diabetology | Full Text
Cureus | Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors: Delving Into the Potential Benefits of Cardiorenal Protection Beyond the Treatment of Type-2 Diabetes Mellitus
Preclinical and clinical SGLT1, SGLT2, and dual SGLT1/2 inhibitors. | Download Scientific Diagram
PharmaWiki - SGLT2-Hemmer
